When stratifying patients according to disease, significant reductions of prohepcidin, CRP and ferritin were detected in CD patients ( p = 0.0231, p = 0.0099, and p = 0.0103, resp.) ( Figure 3 ), whereas UC patients only showed a trend towards a decrease of prohepcidin and CRP ( Figure 4 ).
← all excerpts
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion.
1
—
—